Dermatology evaluation for cutaneous immune related adverse events is associated with improved survival in cancer patients treated with checkpoint inhibition: Supplemental File 1

Published: 12 September 2022| Version 1 | DOI: 10.17632/7vd5tg3ty6.1
Contributors:
Ted Jacoby,
Nishi Shah,
Maria Asdourian,
Leah Thompson,
Tracey Otto,
Nicole LeBoeuf,
Yevgeniy Semenov,
Christopher Dee,
Kerry Reynolds,
Steven Chen

Description

This file includes additional details on study methodology.

Files

Categories

Oncology, Medical Dermatology

License